跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
LOPERAMIDA AUROVITAS 2 MG CAPSULAS DURAS - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
LOPERAMIDA AUROVITAS 2 MG CAPSULAS DURAS
Approved
STANDARD
LOPERAMIDA AUROVITAS 2 MG CAPSULAS DURAS
Aurovitas Spain, S.A.U.
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Jul 21, 2022
Approval ID
6952833e4aaf26cf
Company
Aurovitas Spain, S.A.U.
Type
Standard
Approval Details
Approval Id
6952833e4aaf26cf
Drug Cima Aemps Name
LOPERAMIDA AUROVITAS 2 MG CAPSULAS DURAS
Register Number
87970
Holder Company Name
Aurovitas Spain, S.A.U.
Marketing Company Name
Aurovitas Spain, S.A.U.
Authorization Date
2022-07-21
Dosage Form
CÁPSULA DURA
Dose
2 mg
Route Of Administration
VÍA ORAL
Prescription Type
Sin Receta
Commercialized
Yes
Company Name
Aurovitas Spain, S.A.U.
Active Ingredients
LOPERAMIDA HIDROCLORURO
2 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Jul 21, 2022
Approval ID
6952833e4aaf26cf
Type
Standard
Back to CIMA-AEMPS Approvals